Vitrolife AB
STO:VITR

Watchlist Manager
Vitrolife AB Logo
Vitrolife AB
STO:VITR
Watchlist
Price: 221.4 SEK 4.04% Market Closed
Market Cap: 30B SEK
Have any thoughts about
Vitrolife AB?
Write Note

Vitrolife AB
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vitrolife AB
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Vitrolife AB
STO:VITR
Interest Income Expense
-kr82m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Interest Income Expense
kr27.6m
CAGR 3-Years
N/A
CAGR 5-Years
31%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Interest Income Expense
kr2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Probi AB
STO:PROB
Interest Income Expense
kr8.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Interest Income Expense
-kr1.4B
CAGR 3-Years
-38%
CAGR 5-Years
-47%
CAGR 10-Years
-64%
BioArctic AB
STO:BIOA B
Interest Income Expense
kr12m
CAGR 3-Years
N/A
CAGR 5-Years
26%
CAGR 10-Years
N/A
No Stocks Found

Vitrolife AB
Glance View

Market Cap
30B SEK
Industry
Biotechnology

Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 427 full-time employees. The company went IPO on 2001-06-26. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. The company also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The firm is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

VITR Intrinsic Value
139.61 SEK
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Vitrolife AB's Interest Income Expense?
Interest Income Expense
-82m SEK

Based on the financial report for Sep 30, 2024, Vitrolife AB's Interest Income Expense amounts to -82m SEK.

What is Vitrolife AB's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
24%

Over the last year, the Interest Income Expense growth was 24%.

Back to Top